‹Æ�Ñ
—ߘa1”N“x
Šw�p
�k•½�¬31”N(2019”N)1ŒŽ1“ú�`12ŒŽ31“ú�l
(’˜�‘)
‡V ŒãŠá•”޾г �i1�j–Ô–Œ�E�ÉŽq‘ÌŽ¾Š³ C�DŽü•Ó–Ô–Œ�C�ÉŽq‘ÌŽ¾Š³ 4.uveal effusion
��•û“Þ•ÛŽq
Šá‰È޾г�Å�V‚ÌŽ¡—Ã2019-2021
234-235, “ì�]“° 2019”N3ŒŽ25“ú”�s
4.ŽÎŽ‹ Še˜_ 9�j�ÇŒóŒQ �i2�jƒ�ƒrƒEƒX�ÇŒóŒQ
�¼’q
Šá޾гƒAƒgƒ‰ƒXƒVƒŠ�[ƒY ŠOŠá•”ƒAƒgƒ‰ƒX
336-337, ‘��‡ˆãŠwŽÐ 2019”N10ŒŽ”�s
“Á�W �‚—îŽÒ‚ÆŠáŽ¾Š³�@‰Á—”Á•Ï�«
��•û“Þ•ÛŽq
Pharma Medica vol.37 No.12,
39-42, ƒ�ƒfƒBƒJƒ‹ƒŒƒrƒ…�[ŽÐ 2019”N12ŒŽ”�s
(‘��à)
“œ”A•a‰©”Á•‚Žî‚ÌŽ¡—Ã�–�¨ Trend Therapy for Diabetic Macular Edema
��•û“Þ•ÛŽq
“ú–{Šá‰ÈŠw‰ïŽGŽ� 123 (2): 99-100,2019
(Œ´’˜)
‰p•¶
Clinical characteristics and outcomes of open globe injuries in Japan.
Okamoto Y, Morikawa S, Okamoto F, Inomoto N, Ishikawa H, Ueda T, Sakamoto T, Sugitani K, Oshika T.
Jpn J Ophthalmol. 2019 Jan;63(1):109-118. doi: 10.1007/s10384-018-0638-x.
Diminished circadian blood pressure variability in elderly individuals with nuclear cataracts: cross-sectional analysis in the HEIJO-KYO cohort.
Yoshikawa T, Obayashi K, Miyata K, Nishi T, Ueda T, Kurumatani N, Saeki K, Ogata N.
Hypertens Res. 2019 Feb;42(2):204-210. doi: 10.1038/s41440-018-0140-3.
Effects of concentration of amyloid ƒÀ (AƒÀ) on viability of cultured retinal pigment epithelial cells.
Masuda N, Tsujinaka H, Hirai H, Yamashita M, Ueda T, Ogata N.
BMC Ophthalmol. 2019 Mar 8;19(1):70. doi: 10.1186/s12886-019-1076-3.
Clinical preferences and trends of anti-vascular endothelial growth factor treatments for diabetic macular edema in Japan.
Sugimoto M, Tsukitome H, Okamoto F, Oshika T, Ueda T, Niki M, Mitamura Y, Ishikawa H, Gomi F, Kitano S, Noma H, Shimura M, Sonoda S, Sawada O, Ohji M, Harimoto K, Takeuchi M, Takamura Y, Kondo M, Sakamoto T.
J Diabetes Investig. 2019 Mar;10(2):475-483. doi: 10.1111/jdi.12929.
Association between glaucomatous optic disc and depressive symptoms independent of light exposure profiles: a cross-sectional study of the HEIJO-KYO cohort.
Yoshikawa T, Obayashi K, Miyata K, Ueda T, Kurumatani N, Saeki K, Ogata N.
Br J Ophthalmol. 2019 Aug;103(8):1119-1122. doi: 10.1136/bjophthalmol-2018-312176.
Cataracts and Subclinical Carotid Atherosclerosis in Older Adults�@�\ A Cross-Sectional Study of the HEIJO-KYO Cohort �\
Yoshikawa T, Obayashi K, Miyata K, Nishi T, Ueda T, Kurumatani N, Saeki K, Ogata N.
Circ J. 2019 Sep 25;83(10):2044-2048. doi: 10.1253/circj.CJ-19-0118.
Increased Nighttime Blood Pressure in Patients with Glaucoma: Cross-sectional Analysis of the LIGHT Study.
Yoshikawa T, Obayashi K, Miyata K, Saeki K, Ogata N.
Ophthalmology. 2019 Oct;126(10):1366-1371. doi: 10.1016/j.ophtha.2019.05.019.
Surgical Outcomes of Vitrectomy for Macular Hole Retinal Detachment in Highly Myopic Eyes: A Multicenter Study.
Kakinoki M, Araki T, Iwasaki M, Ueda T, Sano H, Hirano Y, Moriya Y, Sawada O, Takamura Y, Sakamoto T, Kanda T, Ohji M; Japan Clinical Retinal Study Team.
Ophthalmol Retina. 2019 Oct;3(10):874-878. doi: 10.1016/j.oret.2019.04.026.
Risk Factors of Neovascular Glaucoma After 25-gauge Vitrectomy for Proliferative Diabetic Retinopathy with Vitreous Hemorrhage: A Retrospective Multicenter Study.
Takayama K, Someya H, Yokoyama H, Takamura Y, Morioka M, Sameshima S, Ueda T, Kitano S, Tashiro M, Sugimoto M, Kondo M, Sakamoto T, Takeuchi M.
Sci Rep. 2019 Oct 16;9(1):14858. doi: 10.1038/s41598-019-51411-6.
Prognostic factors of revitrectomy for complications in eyes with proliferative diabetic retinopathy: a retrospective multicentre study.
Takayama K, Someya H, Yokoyama H, Kimura T, Takamura Y, Morioka M, Sameshima S, Ueda T, Ogata N, Kitano S, Tashiro M, Sugimoto M, Kondo M, Sakamoto T, Takeuchi M.
Acta Ophthalmol. 2019 Nov 1. doi: 10.1111/aos.14292. [Epub ahead of print]
Real-world management of treatment-naïve diabetic macular oedema in Japan: two-year visual outcomes with and without anti-VEGF therapy in the STREAT-DME study.
Shimura M, Kitano S, Muramatsu D, Fukushima H, Takamura Y, Matsumoto M, Kokado M, Kogo J, Sasaki M, Morizane Y, Kotake O, Koto T, Sonoda S, Hirano T, Ishikawa H, Mitamura Y, Okamoto F, Kinoshita T, Kimura K, Sugimoto M, Yamashiro K, Suzuki Y, Hikichi T, Washio N, Sato T, Ohkoshi K, Tsujinaka H, Kusuhara S, Kondo M, Takagi H, Murata T, Sakamoto T; Japan Clinical Retina Study (J-CREST) group.
Br J Ophthalmol. 2019 Nov 29. pii: bjophthalmol-2019-315199.
doi: 10.1136/bjophthalmol-2019-315199. [Epub ahead of print]
Intraocular pressure elevation after subtenon triamcinolone acetonide injection; Multicentre retrospective cohort study in Japan.
Maeda Y, Ishikawa H, Nishikawa H, Shimizu M, Kinoshita T, Ogihara R, Kitano S, Yamanaka C, Mitamura Y, Sugimoto M, Kondo M, Takamura Y, Ogata N, Ikeda T, Gomi F.
PLoS One. 2019 Dec 5;14(12):e0226118. doi: 10.1371/journal.pone.0226118.
Outcomes of 25-Gauge Vitrectomy for Tractional and Nontractional Diabetic Macular Edema with Proliferative Diabetic Retinopathy
Hideaki Someya, Kei Takayama, Masaru Takeuchi, Hiroshi Yokoyama, Takeshi Kimura, Masakazu Morioka, Yoshihiro Takamura, Seiji Sameshima, Tetsuo Ueda, Nahoko Ogata
, Maki Tashiro, Shigehiko Kitano, Taiji Sakamoto
Journal of Ophthalmology, Volume 2019, ‚ςԂ߂ǂ܂¾
˜a•¶
Ÿ÷‰t�«–Ô–Œ”�—£‚ð”�Ç‚µ‚½ŒXŽÎ“û“ª�ÇŒóŒQ‚̈ê—á
�ƒ’r�ƒ•ã�A‰ª–{‘S�O�A�¼‰ª�r”V�A��•û“Þ•ÛŽq
Šá‰È—Õ�°‹I—v 12Šª10�† Page754-757(2019.10)
“Þ—ÇŒ§—§ˆã‰È‘åŠw•�‘®•a‰@‚É‚¨‚¯‚é�¬Ž™Šá‰È�f—Â̌»‹µ
�¼’q
“Þ—ÇŒ§ˆãŽt‰ïˆãŠw‰ï”N•ñ 32Šª1�† Page10-14(2019.08)
Œõб�Â’f‘wŒv‚É‚æ‚鉩”Á•]‰¿‚ð�s‚Á‚½CHARGE�ÇŒóŒQ‚Ì1—á
”º—T”üŽq�A�¼’q�A��•û“Þ•ÛŽq
Šá‰È—Õ�°‹I—v 12Šª6�† Page457-459(2019.06)
Žv�tŠú”�ÇVogt-�¬–ö-Œ´“c•a‚ɑ΂·‚é‘�ŠúƒVƒNƒ�ƒXƒ|ƒŠƒ““±“ü‚ÌŽŽ‚Ý
ˆÉ“¡—zŽq,�Î�ì’q˜N, �¼’q, “ˆ—ΗÏ
�¬Ž™‰È—Õ�°�@72Šª10�† Page1569-1573(2019.10)
Šw‰ï
�k•½�¬30”N(2018”N)1ŒŽ1“ú�`12ŒŽ31“ú�l
<�‘�ÛŠw‰ï>
ARVO Annual Meeting 2019�i2019”N4ŒŽ28“ú�`5ŒŽ2“ú�@ƒoƒ“ƒN�[ƒo�[�EƒJƒiƒ_�j
�wChange in 1-year visual acuity gain with age-related macular degeneration from 2006 and 2015. �x
S Nishino, T Yasukawa, H Imaizumi, H Mastubara, H Ishikawa, K Kimura, H Terasaki, Y Mitamura, T Murata, M Yamashita, J Kogo, M Takeuchi, Y Takamura, T Murakami, T Sakamoto, M Ohji.
�wChange of baseline visual acuity in eyes with age-related macular degeneration from 2006-2015. �x
T Sawada, T Yasukawa, H Imaizumi, H Mastubara, K Kimura, H Terasaki, H Ishikawa, T Murakami, M Takeuchi, Y Mitamura, M Yamashita, Y Takamura, T Murata, J Kogo, T Sakamoto, M Ohji.
�wRisk and Prognostic Factors of Neovascular Glaucoma After 25-gage Vitrectomy for Proliferative Diabetic Retinopathy with Vitreous Hemorrhage: A Retrospective Multicenter Study.�x
K Takayama, H Someya, H Yokoyama, Y Takamura, M Morioka, S Sameshima, T Ueda, S Kitano, M Tashiro, M Sugimoto, M Kondo, T Sakamoto, M Takeuchi.
<�‘“àŠw‰ï>
‘æ123‰ñ“ú–{Šá‰ÈŠw‰ï‘�‰ï�i2019”N4ŒŽ18“ú�`21“ú�@�ç‘ã“c‹æ�E“Œ‹ž�j
�wƒ|ƒŠ�[ƒv �ó–¬—�–ŒŒŒŠÇ�ǂɂ¨‚¯‚é–¬—�–ŒŠg’£ŒŒŠÇ �i�g pachyvessels�h�j‚ÌŒŸ“¢�x
ˆÉ�W‰@�M•v�AŽR‰º�^—�Žq�A•½ˆä�G�¹�A’†”ö�d�Æ�AŽ¡‘ºŠ°�M�A‰v“c�®“T�A�ã“c“N�¶�A��•û“Þ•ÛŽq
�w—Γà�á�d�Ç“x‚Æ”F’m‹@”\�áŠQ‚ÌŠÖ˜A�x
‹g�ì‹§�é�A‘å—ÑŒ«Žj�A‹{“cŠì”üŒb�A�²”ŒŒ\Œá�A��•û“Þ•ÛŽq
�w–¢�nŽ™–Ô–Œ�ÇŠù‰��Ç—á‚Ì�¬Ž™Šú–¬—�–Œ�\‘¢�x
�¼’q�A�¼�ì—ÇŽq�A–Ø‘º’¼Ž÷�AŒÜ–¡•¶�AŽl‹{‰Á—e�AŽO“c‘º‰À“T�A��•û“Þ•ÛŽq
�wƒAƒ~ƒ�ƒCƒhƒÀ”Z“x•ω»‚É‚æ‚é�Å�I“œ‰»ŽY•¨Žó—e‘Ì�iRAGE�j‚ð‰î‚µ‚½–Ô–Œ�F‘f�ã”ç‘��B�§Œä�x
’Ò’†‘å�¶�A‰v“c�®“T�A•½ˆä�G�¹�AŽR‰º�^—�Žq�A�ã“c“N�¶�A��•û“Þ•ÛŽq
�wŸø�o�«‰Á—”Á•Ï�«1Œ^‚É‚¨‚¯‚é–¬—�–ŒŠg’£ŒŒŠÇ�i�g pachyvessels�h�j‚ÌŒŸ“¢�x
•½ˆä�G�¹�AŽR‰º�^—�Žq�AˆÉ�W‰@�M•v�A’†”ö�d�Æ�AŽ¡‘ºŠ°�M�A�ã“c“N�¶�A��•û“Þ•ÛŽq
�y‘æ72‰ñ“ú–{—Õ�°Šá‰ÈŠw‰ïŠw�p“Wަ—D�G�܉‰‘è�z
�w“Þ—ÇŒ§—§ˆã‰È‘åŠw•�‘®•a‰@‚É‚¨‚¯‚é�Å‹ß3”NŠÔ‚Ì–¢�nŽ™–Ô–Œ�ǂ̔�ǂȂç‚тɎ¡—Ã�ó‹µ�x
�¼’q�A�¼�ì—ÇŽq�A�…àV—T‘¾˜Y�A•õ�³Žu�A‘åŒF�N�O�A��•û“Þ•ÛŽq
�y‘æ72‰ñ“ú–{—Õ�°Šá‰ÈŠw‰ïŠw�p“Wަ—D�G�܉‰‘è�z
�w—Γà�ኳŽÒ‚É‚¨‚¯‚é“_Šá’·ŠúŽg—p‚ÆŠááٔ畆‰Š‚Ƃ̊֘A�x
‹{“c‹G”üŒb�A‹g�ì‹§�é�A�¬�ì�_•½�A�³”©�ç‰Ä�A��•û“Þ•ÛŽq
‘æ75‰ñ“ú–{ŽãŽ‹ŽÎŽ‹Šw‰ï‘�‰ï�E‘æ44‰ñ“ú–{�¬Ž™Šw‰ï‘�‰ï
�i2019”N6ŒŽ14“ú�`15“ú�@•l�¼Žs�E�ɪŒ§�j
�w‘�Šú‚ɃVƒNƒ�ƒXƒ|ƒŠƒ““±“ü‚ð�s‚Á‚½Žv�tŠú”�ÇVogt-�¬–ö-Œ´“c•a‚Ì1—á�x
“¡Œ´�Ž•F�A�¼’q�AˆÉ“¡—zŽq�A�Î�ì’q˜N�A“ˆ—ΗÏ�A��•û“Þ•ÛŽq
“ú–{�‡–°Šw‰ï‘æ44‰ñ’èŠúŠw�p�W‰ï�i2019”N6ŒŽ27“ú�`28“ú�@–¼ŒÃ‰®Žs�Eˆ¤’mŒ§�j
�w—Γà�á�«Ž‹�_Œo“û“ª‚Æ�‡–°‚ÌŽ¿‚ÌŠÖ˜A�F•½�鋞ƒXƒ^ƒfƒB�c’f•ª�Í�x
‹{“c‹G”üŒb�A‘å—ÑŒ«Žj�A‹g�ì‹§�é�AŽR�ã—D‹I�A�ã“c“N�¶�AŽÔ’J“T’j�A�²”ŒŒ\Œá�A��•û“Þ•ÛŽq
‘æ36‰ñ“ú–{Šá�zŠÂŠw‰ï�i2019”N7ŒŽ19“ú�`20“ú�@ŽD–yŽs�E–kŠC“¹�j
ƒVƒ“ƒ|ƒWƒEƒ€ –Ô–¬—�–Œ�zŠÂupdate�wŽ‹‹@”\‚Æ–¬—�–Œ�x
�¼’q
‘æ58‰ñ“ú–{”’“à�áŠw‰ï‘�‰ï�^‘æ45‰ñ�…�»‘ÌŒ¤‹†‰ï
�i2019”N7ŒŽ19“ú�`20“ú�@˜a‰ÌŽRŽs�E˜a‰ÌŽRŒ§�j
�w”’“à�á‚Æ“®–¬�d‰»�U‹»‚ÌŠÖ˜A�F•½�鋞ƒXƒ^ƒfƒB�c’f‰ð�Í�x
‹g�ì‹§�é�A‘å—ÑŒ«Žj�A‹{“c‹G”üŒb�A�²”ŒŒ\Œá�A��•û“Þ•ÛŽq
‘æ73‰ñ“ú–{—Õ�°Šá‰ÈŠw‰ï�i2019”N10ŒŽ24“ú�`27“ú�@‹ž“sŽs�E‹ž“s•{�j
�w�‰�fŽž‚ÉŒõŠo‚È‚µ‚Å‚ ‚Á‚½ŠJ•ú�«ŠáŠO��Šá‚ÌŽ‹—Í—\Œã‚Æ—Õ�°“I“Á’¥�x
—Ñ–¾�O�A�X�ìãÄ•½�A‰ª–{ŽjŽ÷�A’––{�®‹B�A�Î�ì—T�l�A�ã“c“N�¶�A�â–{‘דñ�A�™’J˜a•F�AàV“c�C�A�X��–ç�A�‚‘º‰À�O�A‘厓N˜Y
�w”’“à�áŽè�p‚ªƒ�ƒ‰ƒgƒjƒ“•ª”å‘�‰Á‚É‹y‚Ú‚·‰e‹¿‚ÉŠÖ‚·‚é–³�ìˆ×‰»”äŠrŽŽŒ±�x
�¼’q�A�²”ŒŒ\Œá�A‹{“c‹G”üŒb�A‹g�ì‹§�é�A�ã“c“N�¶�AŽÔ’J“T’j�A‘å—ÑŒ«Žj�A��•û“Þ•ÛŽq
�wDecreased melatonin secretion in severe glaucoma patients�x
Tadanobu Yoshikawa�AKenji Obayashi�AKimie Miyata�AKeigo Sasaki�ANahoko Ogata
‘æ58‰ñ“ú–{–Ô–Œ�ÉŽq‘ÌŠw‰ï‘�‰ï�i2019”N12ŒŽ6“ú�`8“ú�@’·�èŽs�E’·�茧�j
�wPachyvessel‚Ì—L–³‚É‚æ‚éƒ|ƒŠ�[ƒv�ó–¬—�–ŒŒŒŠÇ�Ç�Ç—á‚Ì1”NŒo‰ß‚Ì‘Šˆá�x
“¡Œ´�Ž•F�A’Ò’†‘å�¶�A•½ˆä�G�¹�AŽ¡‘ºŠ°�M�AŽR‰º�^—�Žq�A��•û“Þ•ÛŽq
�wpachychoroid neovasculopathy‚ÆŸø�oŒ^‰Á—”Á•Ï�«‚É‚¨‚¯‚錌Ÿ÷von WillebrandˆöŽq�x
•½ˆä�G�¹�AŽR‰º�^—�Žq�A�ã“c“N�¶�A��•û“Þ•ÛŽq
�w‘��B“œ”A•a–Ô–Œ�Ç‚É�‡•¹‚µ‚½Œ¡ˆø�«–Ô–Œ”�—£‚ɑ΂·‚é‹É�¬�ØŠJ�ÉŽq‘ÌŽè�p‚Ì�pŒãŽ‹—Í‚ð—\‘ª‚·‚éˆöŽq�F‘½Ž{�Ý�‡“¯Œ¤‹†�x
�‚ŽRŒ\�A�õ’J�G•j�A’|“à‘å�A‰¡ŽR�O�A–Ø‘º�„�A�‚‘º‰À�O�A�X‰ª�³˜a�AŽL“‡�½Ž¡�A�â–{‘דñ�A�ã“c“N�¶�A–k–ìŽ •F�A�™–{�¹•F�A‹ß“¡•ô�¶
�‡“¯ŠJ�ÃThe 4th Japan-Taiwan Vitreoretinal Joint Meeting
�wEffect of optical correction on choroidal structure in children with amblyopia�x
�¼’q
<’n•û‰ï>
‘æ17‰ñ“Þ—ÇŒ§Šá‰È–œ—tƒtƒH�[ƒ‰ƒ€�i2019”N6ŒŽ1“ú�@Š€Œ´Žs�E“Þ—ÇŒ§�j
�w—Γà�Ⴊ‚à‚½‚ç‚·�¶‘ÌƒŠƒYƒ€‚ւ̉e‹¿�x
‹g�ì‹§�é
‘æ125‰ñ‹ž“sŠá‰ÈŠw‰ï�i2019”N6ŒŽ9“ú�@‹ž“sŽs�E‹ž“s•{�j
�h‘è•ñ���w�¬Ž™Šá‰È�f—Âɂ¨‚¯‚éOCT‚Ì–ðŠ„�x
�¼’q
‘æ35‰ñ‘啪‘åŠwŠá‰ÈŒ¤‹†‰ï�i2019”N3ŒŽ16“ú�@‘啪Žs�E‘啪Œ§�j
�wŠá‚©‚çƒAƒ“ƒ`ƒGƒCƒWƒ“ƒO�x
��•û“Þ•ÛŽq
<Œ¤‹†‰ï>
‘æ10‰ñŽáŽRŠá޾гŒ¤‹†‰ï�i2019”N6ŒŽ6“ú�@˜a‰ÌŽRŽs�E˜a‰ÌŽRŒ§�j
�w—Γà�Ⴊ‚à‚½‚ç‚· �¶‘ÌƒŠƒYƒ€‚ւ̉e‹¿�x
‹g�ì‹§�é
YOKOHAMA Update Seminar 2019�i2019”N6ŒŽ14“ú�@‰¡•lŽs�E�_“Þ�쌧�j
�w“œ”A•a‰©”Á•‚ŽîŽ¡—Âð�l‚¦‚é�x
��•û“Þ•ÛŽq
‘æ11‰ñRETINAƒtƒH�[ƒ‰ƒ€ in “Þ—Ç�i2019”N6ŒŽ21“ú�@Š€Œ´Žs�E“Þ—ÇŒ§�j
�w–Ô–ŒŒŒŠÇ‚ɑ΂·‚éƒgƒ‰ƒ“ƒXƒŒ�[ƒVƒ‡ƒiƒ‹ƒŠƒT�[ƒ`�x
’Ò’†‘å�¶
‘æ5‰ñ“Þ—ÇŒ§�_ŒoŠá‰ÈƒZƒ~ƒi�[�i2019”N7ŒŽ25“ú�@“Þ—ÇŽs�E“Þ—ÇŒ§�j
�wŽ‹–ì‚ÉŠÖ‚·‚é�Ǘጟ“¢�x
�¼’q
Japan Macular Club 2019�i2019”N8ŒŽ24“ú�@Š—ŒSŽs�Eˆ¤’mŒ§�j
�w–Ô–Œ‚Å“ú“àƒŠƒYƒ€�I�x
��•û“Þ•ÛŽq
NOSC‚̉ï�i2019”N9ŒŽ26“ú�@“Þ—ÇŽs�E“Þ—ÇŒ§�j
�w�RVGEF‚Ì�æ‚Ö�x
’Ò’†‘å�¶
‘æ3‰ñ˜AŒg“o˜^ˆã‚̂‚ǂ¢�i2019”N11ŒŽ2“ú�@Š€Œ´Žs�E“Þ—ÇŒ§�j
�wŠá‚©‚çƒAƒ“ƒ`ƒGƒCƒWƒ“ƒO�x
��•û“Þ•ÛŽq
Novartis Pharma Web Symposium�i2019”N11ŒŽ7“ú�@Š€Œ´Žs�E“Þ—ÇŒ§�j
�w“ޗLjã‘å‚É‚¨‚¯‚éDME‚ÌŽ¡—Ã�x
�ã“c“N�¶
�wDME‚Ì�Å“K‚ÈŽ¡—Âð�l‚¦‚é�x
��•û“Þ•ÛŽq
‘æ27‰ñ“Þ—ÇŒ§‰©”Á޾гŒ¤‹†‰ï�i2019”N12ŒŽ12“ú�@“Þ—ÇŽs�E“Þ—ÇŒ§�j
�wPachychoroid neovasculopathy‚ÆŸø�oŒ^‰Á—”Á•Ï�«‚É‚¨‚¯‚錌Ÿ÷von WillebrandˆöŽq�x
•½ˆä�G�¹�AŽR‰º�^—�Žq�A�ã“c“N�¶�A��•û“Þ•ÛŽq�A�¼–{‰ë‘¥
‘æ9‰ñŽžŠÔ‰uŠwŒ¤‹†‰ï�i2019”N12ŒŽ14“ú�@Š€Œ´Žs�E“Þ—ÇŒ§�j
—Γà�ኳŽÒ‚̊ሳƒŠƒYƒ€�FLIGHTƒXƒ^ƒfƒB
‹g�ì‹§�é�A‘å—ÑŒ«Žj�A‹{“c‹G”üŒb�A�²”ŒŒ\Œá�A��•û“Þ•ÛŽq
<�u�K‰ï>
‘æ2‰ñ“Œ‹žŠá‰ÈƒTƒ~ƒbƒg2019�i2019”N3ŒŽ17“ú�@’†‰›‹æ�E“Œ‹ž“s�j
�wŠá‚©‚çƒAƒ“ƒ`ƒGƒCƒWƒ“ƒO�@“¡Œ´‹žƒXƒ^ƒfƒB/•½�鋞ƒXƒ^ƒfƒB‚©‚ç�x
��•û“Þ•ÛŽq
—ߘaŒ³”N“x‹ß‹EŠá‰Èˆã‰ï˜A�‡‰ÄŠú�u�K‰ï�i2019”N8ŒŽ25“ú�@“Þ—ÇŽs�E“Þ—ÇŒ§�j
�w”’“à�á‚Æ”F’m�Ç�^�¶‘ÌƒŠƒYƒ€�x
��•û“Þ•ÛŽq
<Œ¤‹†Ž‘‹à>
•¶•”‰ÈŠw�È�@Šî”ÕŒ¤‹†�iC�j
Šá‚̉Á—î�«•ω»‚Æ‘S�gˆöŽq�A�¶ŠˆŠÂ‹«�AQOL
Œ¤‹†ŠúŠÔ�F2018-04-01 – 2021-03-31
2019”N“x�F1,560�ç‰~ (’¼�ÚŒo”ï : 1,200�ç‰~�AŠÔ�ÚŒo”ï : 360�ç‰~)
��•û“Þ•ÛŽq
•¶•”‰ÈŠw�È�@Šî”ÕŒ¤‹†�iC�j
—Γà�Ⴊ�¶‘ÌƒŠƒYƒ€‚Ö—^‚¦‚é‰e‹¿‚ÌŒŸ“¢
Œ¤‹†ŠúŠÔ�F2019-04-01 – 2022-03-31
2019”N“x�F1,560�ç‰~ (’¼�ÚŒo”ï: 1,200�ç‰~�AŠÔ�ÚŒo”ï: 360�ç‰~)
‹g�ì‹§�é
•¶•”‰ÈŠw�È�@ŽáŽèŒ¤‹†�iB�j
‘�Šú—Γà�á‚Æ�¶‘ÌƒŠƒYƒ€‚ÉŠÖ‚·‚é‘å‹K–̓Rƒz�[ƒg
Œ¤‹†ŠúŠÔ�F2017-04-01 – 2020-03-31
2019”N“x�F1,300�ç‰~ (’¼�ÚŒo”ï : 1,000�ç‰~�AŠÔ�ÚŒo”ï : 300�ç‰~)
‹{“c‹G”üŒb
Œö‰v�à’c–@�l‘å�ãƒRƒ~ƒ…ƒjƒeƒB�à’c�•�¬Ž–‹Æ
—Γà�Ⴊ�¶‘ÌƒŠƒYƒ€‚É‹y‚Ú‚·‰e‹¿�|‘OŒü‚«ƒRƒz�[ƒgŒ¤‹†ƒx�[ƒXƒ‰ƒCƒ“‰¡’f‰ð�Í�|
2019”N“x�F200,000‰~
‹g�ì‹§�é
ˆê”Ê�à’c–@�l“¡ˆä�ߘY‹L”O‘å�ãŠî‘bˆãŠwŒ¤‹†�§—ã‰ïŒ¤‹†�•�¬‹à
—Γà�Ⴊ�¶‘ÌƒŠƒYƒ€‚Ö—^‚¦‚é‰e‹¿‚̉ð–¾
2019”N“x�F2,000,000‰~
‹g�ì‹§�é
<Žó�Ü>
2019”N Outstanding Research Award�iŽžŠÔ‰uŠwŒ¤‹†‰ï�j
‹g�ì‹§�é